e-learning
resources
ERJ
2007
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum
Bucki R., Byfield F. J., Janmey P. A.
Source:
Eur Respir J 2007; 29: 624-632
Journal Issue:
April
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Bucki R., Byfield F. J., Janmey P. A.. Release of the antimicrobial peptide LL-37 from DNA/F-actin bundles in cystic fibrosis sputum. Eur Respir J 2007; 29: 624-632
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
A 62-year-old man with scanty mucoid sputum
Eosinophilic COPD
Related content which might interest you:
SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition
Source: Eur Respir J 2011; 37: 1083-1090
Year: 2011
Inhaled heparin in cystic fibrosis
Source: Eur Respir J 2006; 27: 354-358
Year: 2006
The antimicrobial peptide CRAMP protects against emphysema
Source: Annual Congress 2012 - Cell culture and animal models of lung disease
Year: 2012
α1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients
Source: Eur Respir J 2007; 29: 240-250
Year: 2007
Anti-inflammatory cytokines in cystic fibrosis lung disease
Source: Eur Respir J 2006; 28: 581-587
Year: 2006
Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence
Source: Eur Respir J 2001; 17: 27-35
Year: 2001
Recombinant human DNase nebulisation in children with cystic fibrosis: before bedtime or after waking up?
Source: Eur Respir J 2007; 30: 763-768
Year: 2007
Characterization of cystic fibrosis airway epithelium
in vitro
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
The chemokine decoy PA401 decreases interleukin-8 and chemotactic activity of cystic fibrosis airway samples
Source: Annual Congress 2013 –Cystic fibrosis: basic and applied science
Year: 2013
Development of secretory leukocyte protease inhibitor (SLPI) variants resistant to degradation by neutrophil elastase
Source: International Congress 2014 – New studies into pulmonary proteases and antiproteases
Year: 2014
Inhibition of airway proteases in cystic fibrosis lung disease
Source: Eur Respir J 2008; 32: 783-795
Year: 2008
Fluticasone reduces IL-6 and IL-8 production of cystic fibrosis bronchial epithelial cells via IKK-β kinase pathway
Source: Eur Respir J 2003; 21: 574-581
Year: 2003
The role of matrix metalloproteinases in cystic fibrosis lung disease
Source: Eur Respir J 2011; 38: 721-727
Year: 2011
The human cathelicidin LL37 and mitochondrial DAMPs induce airway inflammation in epithelial cells and mice
Source: International Congress 2015 – Immunomodulation: basic science and clinical aspects
Year: 2015
Eosinophil cationic protein stimulates TGF-β
1
release by human lung fibroblasts
Source: Annual Congress 2005 - Inflammation and remodelling in allergy and asthma
Year: 2005
Critical role of cytosolic phospholipase A2? in bronchial mucus hypersecretion in CFTR-deficient mice
Source: Eur Respir J 2010; 36: 1120-1130
Year: 2010
Prevalence and clinical significance of auto-antibodies in adults with cystic fibrosis
Source: Eur Respir J 2009; 34: 1079-1085
Year: 2009
Dysregulation of the expression and activity of antimicrobial peptides in COPD and cystic fibrosis
Source: International Congress 2018 – Antimicrobial host defence and innate immunity in the lung
Year: 2018
Ambroxol suppresses influenza-virus proliferation in the mouse airway by increasing antiviral factor levels
Source: Eur Respir J 2002; 19: 952-958
Year: 2002
Expression of HCLCA1 in cystic fibrosis lungs is associated with mucus overproduction
Source: Eur Respir J 2004; 23: 846-850
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept